TY  - CONF

T1  - Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy

JO  - Clinical Cancer Research

UR  - https://eprints.whiterose.ac.uk/id/eprint/131051

UR  - https://doi.org/10.1158/1557-3265.HEMMAL17-18

PY  - 2017/12/01

AU  - Mueller LME

AU  - Parrish C

AU  - Migneco G

AU  - Scott GB

AU  - Holmes M

AU  - Melcher AA

AU  - Lawson MA

AU  - Cook G

AU  - Errington-Mais F

ED  - 

DO  - DOI: 10.1158/1557-3265.HEMMAL17-18

PB  -  American Association for Cancer Research

VL  - 23

IS  - 24

SP  - 18

Y2  - 2025/11/15

ER  -